Metoject 50 mg/ml inj. sol. s.c. pre-filled syr.

Pajjiż: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Methotrexate Sodium 54,84 mg/ml - Eq. Methotrexate 50 mg/ml

Disponibbli minn:

Medac GmbH

Kodiċi ATC:

L01BA01

INN (Isem Internazzjonali):

Methotrexate Sodium

Dożaġġ:

50 mg/ml

Għamla farmaċewtika:

Solution for injection

Kompożizzjoni:

Methotrexate Sodium 54.84 mg/ml

Rotta amministrattiva:

Subcutaneous use

Żona terapewtika:

Methotrexate

Sommarju tal-prodott:

CTI code: 448000-01 - Pack size: 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-02 - Pack size: 4 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-07 - Pack size: 12 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-08 - Pack size: 24 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-03 - Pack size: 5 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-04 - Pack size: 6 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-05 - Pack size: 10 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 448000-06 - Pack size: 11 x 0.25 ml - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2014-01-31

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 11-01-2024
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 11-01-2024
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 11-01-2024
DHPC DHPC Franċiż 14-12-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 11-01-2024
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 11-01-2024
DHPC DHPC Olandiż 14-12-2022